Skip to content
ClinCalc Pro
Menu
Calculators Drugs Pathways AI Dx Donate Get the App
Ocular lubricant (carbomer gel — dry eye disease)

Carbomer 0.2% Eye Gel (Viscotears)

Brand names: Viscotears, GelTears, Liposic

Carbomer 0.2% eye gel (Viscotears) is an ocular lubricant used to relieve dry eye and tear-deficiency states.

Dosing — being independently re-sourced

ClinCalc Pro is rebuilding its dose data from primary open sources — the manufacturer SmPC (eMC), the WHO Model Formulary and other official references — under clinician review. This drug's structured dose is not yet published here. Confirm all doses against the product SmPC and your local formulary before prescribing.

Clinical monograph

How it works

The high-molecular-weight polyacrylic acid polymer forms a mucomimetic film that adheres to the ocular surface, prolonging tear-film contact time and stabilising the precorneal tear film.

Prescribing in practice

  • Causes transient blurred vision after application, so it is often best reserved for night-time or spaced from other treatments.
  • If other eye drops are used concurrently, instil the gel last and allow an interval between products.
  • Discontinue and review if ocular irritation or signs of hypersensitivity develop.

Monitoring

No laboratory monitoring is needed; review symptomatic relief and ocular surface comfort and reassess if symptoms persist or worsen.

Counselling the patient

  • Expect short-lived blurring after application; avoid driving until vision clears.
  • Remove soft contact lenses before applying unless advised otherwise.
  • Discard within the period stated on the packaging once opened to reduce contamination risk.

Evidence & guidelines

Ocular lubricants are the mainstay of symptomatic management of dry eye disease, with choice guided by symptom severity and patient preference.

Reference: DEWS II Report 2017; Viscotears SPC; Drug verified in RxNorm (NLM); confirm dosing against the manufacturer SPC (eMC). Verify against your local formulary and current prescribing references before prescribing. Monograph status: clinician-reviewed (2026-07-04).

Related

Curated clinical cross-links plus same-class fallbacks.

Calculators
Pathways